Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.
about
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicityEndocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damageProtective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell deathEffect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats.Targeting the endocannabinoid system in treating brain disorders.Cannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury.Role of cannabinoids and endocannabinoids in cerebral ischemia.Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring miceDrug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.The endocannabinoid system as a target for the treatment of neuronal damage.The multiplicity of action of cannabinoids: implications for treating neurodegeneration.Cannabinoids, multiple sclerosis and neuroprotection.Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection.Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol.In Vivo Multimodal Magnetic Resonance Imaging Changes After N-Methyl-d-Aspartate-Triggered Spasms in Infant Rats.Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in miceThe Endocannabinoid System and Oligodendrocytes in Health and Disease
P2860
Q33638542-C347F296-9B0F-4EDA-919E-AF5839DD3840Q35546025-74067DDC-3478-45B0-8266-7523AF006CA7Q35682377-8A718D3B-3F15-40C3-B4A7-0CEBBD731E8AQ36357902-01F0D895-3390-431C-AADD-96E7A9EF3310Q36425999-0C83A82B-8E1F-4426-8D61-58446767CF11Q36634698-3D7AA448-9F34-4B35-B351-EDFE4F411C43Q36967863-A924262D-7504-4C53-A69A-F025BFB940D1Q37153885-1DA15D6A-46B8-41B3-84F8-6B987A471D79Q37211892-884113A6-A24F-458E-97F9-5983EB65428CQ37709370-4688EC6A-8F6B-47D8-A1E1-E990F10B7A8BQ37793366-1D93014D-C283-4FE8-A012-5544CDEDE2B0Q37960199-FE3E8632-2C8B-4785-B40A-049A67340834Q38756777-F4A7AF98-B43B-43D8-B8FC-A8EDBC977BFDQ45943797-B2D4A24B-495F-49EB-9EA0-31EFFAE46419Q46615751-1D84768A-C39D-40AC-8F34-04BBAD003E26Q48089296-B6F732D2-4743-4737-9671-819505F217C9Q55402439-81185F21-B265-4A26-878D-B9676544A702Q58331887-F2071A71-15DA-458F-BC19-63722C38BFE1Q58707257-D1568D9C-804C-4079-BE5F-D545BEDE5A93
P2860
Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Blockade of cannabinoid CB
@nl
Blockade of cannabinoid CB(1) ...... g NMDA-induced excitotoxicity.
@en
type
label
Blockade of cannabinoid CB
@nl
Blockade of cannabinoid CB(1) ...... g NMDA-induced excitotoxicity.
@en
prefLabel
Blockade of cannabinoid CB
@nl
Blockade of cannabinoid CB(1) ...... g NMDA-induced excitotoxicity.
@en
P2093
P2860
P50
P921
P1476
Blockade of cannabinoid CB(1) ...... ng NMDA-induced excitotoxicity
@en
P2093
Harald S Hansen
Henrik H Hansen
Javier Fernández-Ruiz
José Antonio Ramos
P2860
P304
P356
10.1046/J.1471-4159.2002.00961.X
P407
P577
2002-07-01T00:00:00Z